SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: manfredhasler who wrote (14691)9/17/2000 9:12:04 AM
From: aknahow  Read Replies (2) of 17367
 
Manfred, in the U.K. there has been a massive p.r. campaign for years to get parents to recognize the signs of meningococcemia as early as possible and to seek treatment. The bottle or glass test, is part of this campaign and something I wish had been incorporated into U.S, health awareness. For years any and almost all comments in the u.k. media, including journals cooperate with this effort by stressing the importance of parental education.

The doctors who worked on the trial and wrote the paper, should not in any way be denigrated for cooperation with this effort. In fact there is much to be said for this effort continuing even when an absolute cure is found for meningococcemia. The best drug will do no good if parents procrastinate and think it is the flu, or a cold.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext